Medications
Pfizer breast cancer drug to get FDA priority review
Pfizer said Monday an experimental breast cancer treatment will be given an accelerated review by US regulators, speeding up the process for potential approval.
Oct 13, 2014
0
0
Page 31 - News tagged with pfizer
Medications
Safety advocates seek stronger warnings on Chantix (Update)
Public safety advocates are asking the federal government to strengthen warnings on Pfizer's anti-smoking drug Chantix, even as the drugmaker prepares to argue that a bold-letter warning about psychiatric problems should ...
Oct 8, 2014
0
0
Medications
Viagra ads target women for first time
The maker of the world's top-selling erectile dysfunction drug on Tuesday will begin airing the first Viagra TV commercial in America that targets the less-obvious sufferers of the sexual condition: women.
Sep 30, 2014
0
0
Medications
New FDA label bolsters safety case for Chantix
New government-approved labeling on Pfizer's drug Chantix suggests that the anti-smoking medication may not carry the risks of suicidal behavior that first earned it the Food and Drug Administration's strongest warning more ...
Sep 24, 2014
0
0
Medications
Pfizer to pay $35M to settle drug marketing case
Pfizer will pay $35 million to resolve allegations by 42 states that its subsidiary, Wyeth Pharmaceuticals, illegally marketed an organ transplant drug for unapproved uses.
Aug 6, 2014
0
0
Medications
Pfizer pulls plug on push to buy AstraZeneca (Update 2)
Pfizer said Monday that it does not intend to make a takeover offer for British drugmaker AstraZeneca, pulling the plug for now on what would have been the largest deal in the industry's history.
May 26, 2014
0
0
Medications
AstraZeneca rejects $119 billion offer from Pfizer (Update)
The board of AstraZeneca on Monday rejected the improved $119 billion takeover offer from U.S. drugmaker Pfizer, a decision that caused a sharp slide in the U.K. company's share price as many investors think it effectively ...
May 19, 2014
0
0
Oncology & Cancer
Pfizer seeks early approval for breast cancer drug
Pfizer Inc. says the Food and Drug Administration will let the drugmaker apply for approval of its heavily touted experimental breast cancer medicine based on midstage patient testing results.
May 16, 2014
0
0
Other
Pfizer underscores UK commitments in memo (Update)
Pfizer Inc. has sought to allay concerns over its proposed $106 billion takeover offer of Anglo-Swedish pharmaceuticals firm AstraZeneca, insisting that its promises will be legally binding.
May 12, 2014
0
0
Other
Pfizer argues for AstraZeneca deal in web videos
Pfizer posted videos online Saturday in its latest effort to win over critics of its proposed purchase of British drugmaker AstraZeneca.
May 10, 2014
0
0
